Our portfolio

To date, CEPI has established multiple partnership agreements, reflecting a potential investment of up to $480 million. Through these collaborations, we're supporting the development of a wide range of vaccine candidates and platform technologies.

CEPI is also funding seven programmes which aim to rapidly advance the development of vaccine candidates against the COVID-19 virus.